179 related articles for article (PubMed ID: 37973705)
21. Complete down-regulation of low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2 by beta-migrating very-low-density lipoprotein and non-lipoprotein cholesterol. Different cellular regulatory pools of cholesterol.
Kamps JA; van Berkel TJ
Eur J Biochem; 1992 Jun; 206(3):973-8. PubMed ID: 1318843
[TBL] [Abstract][Full Text] [Related]
22. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.
Forster LF; Stewart G; Bedford D; Stewart JP; Rogers E; Shepherd J; Packard CJ; Caslake MJ
Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202
[TBL] [Abstract][Full Text] [Related]
23. Regulation of plasma triglycerides in insulin resistance and diabetes.
Ginsberg HN; Zhang YL; Hernandez-Ono A
Arch Med Res; 2005; 36(3):232-40. PubMed ID: 15925013
[TBL] [Abstract][Full Text] [Related]
24. Fenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE*3-Leiden.CETP mice.
Bijland S; Pieterman EJ; Maas AC; van der Hoorn JW; van Erk MJ; van Klinken JB; Havekes LM; van Dijk KW; Princen HM; Rensen PC
J Biol Chem; 2010 Aug; 285(33):25168-75. PubMed ID: 20501652
[TBL] [Abstract][Full Text] [Related]
25. [The effect of khellin and timefurone on secretion and catabolism of lipoproteins by cultured human and rabbit hepatocytes].
Volgushev SA; Kosykh VA; Podrez EA; Novikov DK; Fuki IV; Karpov RS; Repin VS
Biokhimiia; 1990 Feb; 55(2):346-51. PubMed ID: 2340318
[TBL] [Abstract][Full Text] [Related]
26. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
[TBL] [Abstract][Full Text] [Related]
27. Conformational changes in apolipoprotein B modulate intracellular assembly and degradation of ApoB-containing lipoprotein particles in HepG2 cells.
Macri J; Adeli K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2982-94. PubMed ID: 9409285
[TBL] [Abstract][Full Text] [Related]
28. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
29. Metabolism of apoprotein B in selectively bred baboons with low and high levels of low density lipoproteins.
Kushwaha RS; Barnwell GM; Carey KD; McGill HC
J Lipid Res; 1986 May; 27(5):497-507. PubMed ID: 3734633
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
[TBL] [Abstract][Full Text] [Related]
31. Hepatic apolipoprotein E expression promotes very low density lipoprotein-apolipoprotein B production in vivo in mice.
Maugeais C; Tietge UJ; Tsukamoto K; Glick JM; Rader DJ
J Lipid Res; 2000 Oct; 41(10):1673-9. PubMed ID: 11013310
[TBL] [Abstract][Full Text] [Related]
32. Method to measure apolipoprotein B-48 and B-100 secretion rates in an individual mouse: evidence for a very rapid turnover of VLDL and preferential removal of B-48- relative to B-100-containing lipoproteins.
Li X; Catalina F; Grundy SM; Patel S
J Lipid Res; 1996 Jan; 37(1):210-20. PubMed ID: 8820116
[TBL] [Abstract][Full Text] [Related]
33. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
[TBL] [Abstract][Full Text] [Related]
34. Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2.
Dashti N; Alaupovic P; Knight-Gibson C; Koren E
Biochemistry; 1987 Jul; 26(15):4837-46. PubMed ID: 2822101
[TBL] [Abstract][Full Text] [Related]
35. Role of the neutral lipid accessible pool in the regulation of secretion of apoB-100 lipoprotein particles by HepG2 cells.
Avramoglu RK; Cianflone K; Sniderman AD
J Lipid Res; 1995 Dec; 36(12):2513-28. PubMed ID: 8847478
[TBL] [Abstract][Full Text] [Related]
36. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
Venkatesan N; Devaraj SN; Devaraj H
Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
[TBL] [Abstract][Full Text] [Related]
37. The activity of microsomal triglyceride transfer protein is essential for accumulation of triglyceride within microsomes in McA-RH7777 cells. A unified model for the assembly of very low density lipoproteins.
Wang Y; Tran K; Yao Z
J Biol Chem; 1999 Sep; 274(39):27793-800. PubMed ID: 10488124
[TBL] [Abstract][Full Text] [Related]
38. Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men.
Riches FM; Watts GF; Hua J; Stewart GR; Naoumova RP; Barrett PH
J Clin Endocrinol Metab; 1999 Aug; 84(8):2854-61. PubMed ID: 10443691
[TBL] [Abstract][Full Text] [Related]
39. The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions.
Fu T; Mukhopadhyay D; Davidson NO; Borensztajn J
J Biol Chem; 2004 Jul; 279(27):28662-9. PubMed ID: 15123680
[TBL] [Abstract][Full Text] [Related]
40. Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice.
López-Parra M; Titos E; Horrillo R; Ferré N; González-Périz A; Martínez-Clemente M; Planagumà A; Masferrer J; Arroyo V; Clària J
J Lipid Res; 2008 Dec; 49(12):2513-23. PubMed ID: 18645210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
